NCT00614016

A Phase 1, Single-Dose Safety and Pharmacokinetic Study of Sodium ST20 in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: HemaQuest Pharmaceuticals Inc. · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

A safety and pharmacokinetic study of a single dose of ST20 in healthy volunteers

Detailed description

A Phase 1 study in healthy volunteers to assess the safety and pharmacokinetics of ST20 after oral administration of a single-dose. In addition, a comparison of the pharmacokinetics and exposure of a single dose of ST20 under fasting and non-fasting conditions will be assessed.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Sodium ST20	single administration of oral dosage form

Timeline

• Start date: 2008-01-01
• Primary completion: 2008-04-01
• Completion: 2008-06-01
• First posted: 2008-02-13
• Last updated: 2008-08-05

Locations

1 site across 1 country: United States